Becoming a colposcopist: Colposcope case studies

Size: px
Start display at page:

Download "Becoming a colposcopist: Colposcope case studies"

Transcription

1 Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University

2 Value of Colposcopy Cytology is an effective screening method, and colposcopy with directed biopsy is the critical diagnostic step for women with cervical cytologic abnormalities Decrease diagnostic conization and hysterectomy. Limitation; It takes some time and experience to properly analyze what you see.

3 Role of colposcopist 1. Colposcopist must be able to locate the disease. 2. Colposcopically assess the severity of lesions. 3. Determine the most severe lesion to biopsy. 4. Correlate the colposcopic impression with the cytologic and histologic findings. 5. Then the colposcopist determines the appropriate management or treatment.

4 Practical knowledge Precisely localise TZ, Recognize normal and abnormal TZ, TZ with gland opening, sq.met aplasia, columnar epithelium Clinical skills Punch biopsy, LLETZ

5 Colposcopy: Work-up Explain to the patient. Inspect the vagina and cervix and apply 3-5% acetic acid. Position the colposcope and focus on the cervix with the desired magnification (7X-15X). Drawings the lesion topography and lesion grade(s) Biopsy samples should be obtained from all abnormal lesions. A cytobrush or ECC may be used to evaluate the endocervical pathology. Hemostatic agent can be applied to each biopsy site. Results should be reviewed to confirm.

6 Diagnostic accuracy of colposcopy Calculated based on the agreement of the colposcopic impression with the histologic interpretation within one histologic grade. Limitations; Colposcopy is highly sensitive in well-trained hands, but has low specificity, and, thus, is not a good screening tool.

7 Colposcopical scoring system Colposcopy is a subjective diagnostic method with high sensitivity and low specificity. Because of low specificity, the scoring system for colposcopic findings is important when deciding on the necessity of cervical biopsy, and it contributes to the decreasing of unnecessary biopsy.

8 Colposcopic accuracy The colposcopic accuracy index threshold of 80% appears to be a reasonable proficiency level and a useful goal for training programs. The colposcopist may overestimate minor benign cervical epithelial and vascular alterations that mimic low-grade premalignant disease features. The error is common when the colposcopist has knowledge of a preexisting minor cytologic smear abnormality.

9 Colpo. Appearance of Benign Lesions Keratosis, Erosions and Ulcers, Cervicitis, Atrophy, Nabothian cysts, Ectopy, Deciduosis, Endometriosis, Endocervical polyps. The difficulty lies in learning to distinguish lowgrade lesions from immature metaplasia which also exhibits aceto-whitening and fine vascular patterns. Due to the variability of the colposcopic appearance of low-grade lesions, the accuracy and reproducibility of diagnosis is less than that of higher grade lesions.

10 Colpo. Appearance of Benign Lesions nabothian cyst cervical polyp

11 Colpo. Appearance of Benign Lesions immature squamous metaplasia(pinkish white hue) crypt opening

12 Colpo. Appearance of Benign Lesions immature squamous metaplasia mild acetowhite lesion with fine mosaic and irregular margin

13 Colpo. Appearance of LSIL Flat with a smooth surface, except condylomas. Leukoplakia ; benign hyperkeratosis or low-grade HPV lesions. Variable aceto-whitening; faint Irregular, feathered or geographic outer borders. Partial iodine uptake Either featureless or have fine mosaicism or punctation.

14 Colpo. appearance of Low Grade Lesion mildly dense acetowhite lesion irregular geographical margin

15 Colpo. appearance of HPV infection Condylomas may arise within TZ or as skip lesions within the mature squamous epithelium. The papillary spike-like projections of acuminate warts and the regular projections(asperites) on surface of flat condylomas with colposcopic magnification. It also may be a bright aceto-white, which is characteristic of condyloma.

16 Colpo. appearance of HPV infection The bright aceto-white and the asperites on the surface

17 Colpo. appearance of HSIL Sharply demarcated lesion edges lesion within a lesion or border within a border More prompt and persistent aceto-white change Absence of vessels due to increased lesion density Coarse vascular patterns (punctation, mosaicism, or both), Umbilicated mosaic patterns suggests CIN 3 / carcinoma-in-situ.

18 Colpo. appearance of HSIL dense acetowhite lesion with sharp demarcated margins internal borders within lesion

19 Colpo. appearance of HSIL dense acetowhite lesion with rolled out margins coarse punctation and mosaic with umbilication

20 HSIL site and Topography The most severe disease is found at the most proximal (cephalad) extent of lesion. Size of lesions variable but tends to correlate with severity of disease and risk of occult invasion Size of lesion correlates with risk of treatment failure

21 Colpo. Findings of Adenocarcinoma in Situ The colposcopic findings are often subtle and nonspecific. The two primary findings are (1) a wide area of eversion and (2) ginger root like vessels. Approximately 40% of adenocarcinoma in situ (ACIS) will have an associated SIL. ASCCP guidelines for AGC require colposcopic evaluation and directed biopsies, ECC and D&C for women over 35 years of age.

22 Colpo. Findings of Adenocarcinoma in Situ Pap; ASC-H, HPV(HC); - Biopsy: AIS endocervix CIS exocervix Pap ; HSIL, HPV; 18+ Biopsy; adenocarcinoma, eversion and root like vessels.

23 Colpo. appearance of Invasive cancer The surface is irregular but the borders tend to be sharply defined. In some cases, subtle ulceration can be the only feature present. exophytic mass ulcerative lesion; 12-3 oclock

24 Vaginal colposcopy Indicated when cytology suggests disease in: 1) patients with a normal cervix 2) in patients in whom the cervix is absent The entire surface area of the vagina is examined, including that behind the blades of the speculum. In post hysterectomy patients, the lateral invagination of the vaginal vault must be carefully evaluated. Areas of VaIN are typically discrete with slightly elevated borders and are pinkish or white in color.

25 Colpo. appearance of VaIN Pap; HSIL post-tah state, Pap; mod.dysplasia

26 Colposcopy in pregnant women Cervix must be handled atraumatically in order to avoid bleeding of the congested, hyperaemic tissues. The degree of acetowhitening and the confusing angioarchitecture, with coarse punctation and mosaicism, may give the impression that the lesion is severer than it is.

27 Colposcopy During Pregnancy Increased vascularity produces a cyanotic, bluish hue. progressive eversion of the scj onto the ectocervix makes colposcopy satisfactory more often.

28 CASE STUDY 23 year old Pap ; benign cellular change Colpo.index; 0-2, SPI Bx ; 10 o clock, chonic cervicitis HPV(HC); negative

29 CASE STUDY 53 year old Pap ; LSIL Colpo.index; 3-5, r/o HSIL Bx ; 10 o'clock CIS HPV(HC); positive

30 CASE STUDY 38 year old Pap ; AGUS Colpo.index; 0-2, r/o endocervical lesion Bx ; 5 o'clock cervicitis HPV(HC); negative Dx Tx conization

31 CASE STUDIES from ASCCP

32 CASE STUDY from ASCCP A 25-year-old G2 P1011, her first Pap test showed ASC-US. She was then lost to follow-up until this current examination. Question The cytology shows: a. negative for intraepithelial lesion or malignancy. b. ASC-US. c. LSIL d. HSIL

33 CASE STUDY from ASCCP A 25-year-old G2 P1011, her first Pap test showed ASC-US. She was then lost to follow-up until this current examination. Question The cytology shows: a. negative for intraepithelial lesion or malignancy. b. ASC-US. c. LSIL d. HSIL

34 The patient was evaluated with colposcopy. Question 1 Colposcopic findings include: a. atypical vessels, corkscrew vessels. b. coarse mosaic pattern with punctation and sharp borders. c. microglandular hyperplasia. d. cervical ectopy. e. condyloma. Question 2 The most likely colposcopic impression is: a. metaplasia, cervicitis. b. CIN 1. c. CIN 3. d. microinvasive cancer.

35 The patient was evaluated with colposcopy. Question 1 Colposcopic findings include: a. atypical vessels, corkscrew vessels. b. coarse mosaic pattern with punctation and sharp borders. c. microglandular hyperplasia. d. cervical ectopy. e. condyloma. Question 2 The most likely colposcopic impression is: a. metaplasia, cervicitis. b. CIN 1. c. CIN 3. d. microinvasive cancer.

36 CASE STUDY from ASCCP A 26 year-old woman, G4 P2012, was seen for her first prenatal visit at 9 weeks gestation. A Pap test at that time was read as HSIL. Her previous Pap test results, performed 3 years ago, was read as normal. Question The next step in the management of this patient is: a. To repeat Pap test in 3 months. b. reflex testing for high-risk human papillomavirus. c. immediate colposcopy. d. colposcopy post partum.

37 CASE STUDY from ASCCP A 26 year-old woman, G4 P2012, was seen for her first prenatal visit at 9 weeks gestation. A Pap test at that time was read as HSIL. Her previous Pap test results, performed 3 years ago, was read as normal. Question The next step in the management of this patient is: a. To repeat Pap test in 3 months. b. reflex testing for high-risk human papillomavirus. c. immediate colposcopy. d. colposcopy post partum.

38 The patient underwent a colposcopy at 13 weeks' gestation. Question 1 What colposcopic features are present in Figures? a. fine punctation. b. coarse mosaic pattern with punctation. c. leukoplakia. d. atypical blood vessels. Question 2 The colposcopic impression is: a. CIN 1. b. CIN 2. c. CIN 3. d. microinvasive cancer. e. Either (b) or (c).

39 The patient underwent a colposcopy at 13 weeks' gestation. Question 1 What colposcopic features are present in Figures? a. fine punctation. b. coarse mosaic pattern with punctation. c. leukoplakia. d. atypical blood vessels. Question 2 The colposcopic impression is: a. CIN 1. b. CIN 2. c. CIN 3. d. microinvasive cancer. e. Either (b) or (c).

40 The patient was seen again at 28 weeks with no change in the colposcopic impression. She delivered at term and was seen back in the clinic at 6 weeks postdelivery. At that time, a Pap test and colposcopy were done. Question The colposcopic impression is: a. CIN 1. b. CIN 2. c. CIN 3. d. normal.

41 The patient was seen again at 28 weeks with no change in the colposcopic impression. She delivered at term and was seen back in the clinic at 6 weeks postdelivery. At that time, a Pap test and colposcopy were done. Question The colposcopic impression is: a. CIN 1. b. CIN 2. c. CIN 3. d. normal.

42 CASE STUDY from ASCCP A 26 year old G1 P1001 presented for evaluation of a LSIL Pap test. In this clinic, women found to have ASCUS x 2 or LSIL Paps were invited to enroll in an IRB approved study conducted through the local University. Women with biopsy-proven CIN1 or less were followed with surveillance Paps and Cervicography every 4-6 months and annual colposcopy. In this case, HPV DNA is positive for High Risk (HR) types.

43 The cervigram and findings of her repeat cytology Question 1 Her initial cervigram was interpreted as: a. negative; normal cervix; squamous metaplasia b. positive; compatible with low grade lesion c. positive; probable normal variant d. positive; compatible with high grade lesion Question 2 The cytology shows: a. negative for intraepithelial lesion or malignancy b. atypical squamous cells of undetermined significance c. LSIL; parakeratosis d. high grade squamous intraepithelial lesion

44 The cervigram and findings of her repeat cytology Question 1 Her initial cervigram was interpreted as: a. negative; normal cervix; squamous metaplasia b. positive; compatible with low grade lesion c. positive; probable normal variant d. positive; compatible with high grade lesion Question 2 The cytology shows: a. negative for intraepithelial lesion or malignancy b. atypical squamous cells of undetermined significance c. LSIL; parakeratosis d. high grade squamous intraepithelial lesion

45 14 months after initial enrollment, the image of her cervix is shown (Figure ). HPV DNA is positive for HR types. Question 1 Colposcopic findings seen include: a. atypical vessels, corkscrew vessels, condyloma b. dense acetowhite epithelium; absent vessels; straight border c. mosaic d. cervical ectopy Question 2 The next step in her management would be: a. re-appoint for study follow-up in 4-6 months b. repeat colposcopy and biopsy c. LLETZ c. cryosurgery

46 14 months after initial enrollment, the image of her cervix is shown (Figure ). HPV DNA is positive for HR types. Question 1 Colposcopic findings seen include: a. atypical vessels, corkscrew vessels, condyloma b. dense acetowhite epithelium; absent vessels; straight border c. mosaic d. cervical ectopy Question 2 The next step in her management would be: a. re-appoint for study follow-up in 4-6 months b. repeat colposcopy and biopsy c. LLETZ c. cryosurgery

47 CASE STUDY from ASCCP 20 year old Female G0 with a history of LSIL presented to another colposcopist. Question This colposcopic image is most consistent with: a. satisfactory colposcopy, three low-grade acetowhite lesions seen. b. unsatisfactory colposcopy, no evidence of any abnormalities. c. unsatisfactory colposcopy, endocervical lesion seen. d. satisfactory colposcopy, one abnormal lesion seen at 5- to 7-o'clock. e. None of the above.

48 CASE STUDY from ASCCP 20 year old Female G0 with a history of LSIL presented to another colposcopist. Question This colposcopic image is most consistent with: a. satisfactory colposcopy, three low-grade acetowhite lesions seen. b. unsatisfactory colposcopy, no evidence of any abnormalities. c. unsatisfactory colposcopy, endocervical lesion seen. d. satisfactory colposcopy, one abnormal lesion seen at 5- to 7-o'clock. e. None of the above.

49 Question 1 During colposcopy, the preferred course of action would be: a. no biopsies necessary. b. to biopsy the lesion at 5- to 7-o'clock position. c. to perform ECC only. d. to perform multiple biopsies of lesions noted that appear abnormal. e. immediate LEEP at the time of colposcopy. Question 2 The preferred course of management would be: a. LEEP b. cryotherapy. c. return colposcopy evaluation within 6 months. d. vaginal antibiotic therapy, e. conization with ECC

50 Question 1 During colposcopy, the preferred course of action would be: a. no biopsies necessary. b. to biopsy the lesion at 5- to 7-o'clock position. c. to perform ECC only. d. to perform multiple biopsies of lesions noted that appear abnormal. e. immediate LEEP at the time of colposcopy. Question 2 The preferred course of management would be: a. LEEP b. cryotherapy. c. return colposcopy evaluation within 6 months. d. vaginal antibiotic therapy, e. conization with ECC

51 CASE STUDY from ASCCP A 19-year-old, G0, presents for evaluation after a Pap test showing a LSIL. This was her first abnormal Pap test and her previous Pap test 1 year earlier was normal. Her coitarche at age 16 years, and 12 total lifetime sexual partners. The patient returned 1 year later for a repeat Pap test. This time the Pap was reported as HSIL.

52 The patient underwent a colposcopic examination with a biopsy. Question 1 The colposcopic appearance of the cervix was most consistent with: a. squamous metaplasia b. CIN 1 c. CIN 2,3 d. adenocarcinoma in situ (AIS) e. squamous carcinoma Question 2 The histological diagnosis is consistent with: a. squamous metaplasia b. mild dysplasia (CIN 1) c. moderate dysplasia (CIN 2) d. severe dysplasia (CIN 3) e. squamous carcinoma

53 The patient underwent a colposcopic examination with a biopsy. Question 1 The colposcopic appearance of the cervix was most consistent with: a. squamous metaplasia b. CIN 1 c. CIN 2,3 d. adenocarcinoma in situ (AIS) e. squamous carcinoma Question 2 The histological diagnosis is consistent with: a. squamous metaplasia b. mild dysplasia (CIN 1) c. moderate dysplasia (CIN 2) d. severe dysplasia (CIN 3) e. squamous carcinoma

54 CASE STUDY from ASCCP A 27-year-old, G5 P3013, presents to the clinic for prenatal care at 20 weeks. The patient has a history of abnormal Pap tests dating back 7 years. Colposcopic exams and biopsies have shown low-grade squamous intraepithelial lesion (LSIL). Her last Pap test 2 years ago was normal. The patient s current Pap test was read as HSIL.

55 Question 1 The findings on colposcopy are consistent with: a. CIN 1 b. CIN 2,3 c. invasive cancer d. metaplasia Question 2 The next step in the management of this patient is: a. repeat cytology and colposcopy in 8 weeks b.repeat cytology and colposcopy in 12 Weeks c. cold-knife conization d. repeat cytology and colposcopy 6 weeks postpartum e. either (b) or (d)

56 Question 1 The findings on colposcopy are consistent with: a. CIN 1 b. CIN 2,3 c. invasive cancer d. metaplasia Question 2 The next step in the management of this patient is: a. repeat cytology and colposcopy in 8 weeks b. repeat cytology and colposcopy in 12 weeks c. cold-knife conization d. repeat cytology and colposcopy 6 weeks postpartum e. either (b) or (d)

57 CASE STUDY from ASCCP A 22-year-old presents with HPV positive ASC-US Papanicoloau smear. She has no previous history of abnormal Pap smears and has been screened in the past. She does not smoke. Question Appropriate management options for this patient include: a. repeat HPV testing in 12 months b. Pap at 6 and 12 months c. colposcopy d. HPV DNA specific typing

58 CASE STUDY from ASCCP A 22-year-old presents with HPV positive ASC-US Papanicoloau smear. She has no previous history of abnormal Pap smears and has been screened in the past. She does not smoke. Question Appropriate management options for this patient include: a. repeat HPV testing in 12 months b. Pap at 6 and 12 months c. colposcopy d. HPV DNA specific typing

59 Consensus guidelines for the management of women with abnormal cervical cancer screening tests ASC-H, LGSIL, HGSIL, squamous cell cancer: colposcopic evaluation and biopsy of abnormal sites is recommended. ASC-US: Repeat cytologic evaluation at 6 and 12 months Reflex testing for the presence of high-risk HPV serotypes. If either of these strategies results in abnormal findings, colposcopy is indicated. AGC: colposcopic, endocervical and endometrial evaluation, and sampling in addition to HPV testing. AIS, adenocarcinoma: excisional procedures

60 Question 1 The best answer which fits this colposcopic picture is: a. satisfactory colposcopy with high grade lesion b. unsatisfactory colposcopy with no lesion seen c. satisfactory colposcopy no lesion seen d. satisfactory colposcopy with low grade lesion seen Question 2 Which management option is NOT appropriate in this patient: a. ECC b. repeat Pap and HPV in 6-12 months c. HPV DNA testing for high risk virus at 12 months d. loop excision

61 Question 1 The best answer which fits this colposcopic picture is: a. satisfactory colposcopy with high grade lesion b. unsatisfactory colposcopy with no lesion seen c. satisfactory colposcopy no lesion seen d. satisfactory colposcopy with low grade lesion seen Question 2 Which management option is NOT appropriate in this patient: a. ECC b. repeat Pap and HPV in 6-12 months c. HPV DNA testing for high risk virus at 12 months d. loop excision

62 Thank you!

63 이선경 연자약력 ; 경희대학교의과대학의학과졸업 미국 Vanderbilt university medical center special fellowships in gynecologic oncology 경희대학교동서신의학병원산부인과과장경희대학교의과대학산부인과주임교수 학회활동 : 대한부인종양 - 콜포스코피학회 ; 이사, 학술위원회위원대한부인종양연구회연구위원회위원대한산부인과학회 ; 이사, 학술위원회위원, 논문심사위원한국자궁경부확대촬영연구회판독위원, 회장미국질확대경 - 자궁경부병리학회정회원세계부인암학회정회원

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

Cervical Dysplasia and HPV

Cervical Dysplasia and HPV Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk

More information

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%

More information

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy 1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous

More information

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This

More information

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Management Algorithms for Abnormal Cervical Cytology and Colposcopy Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent

More information

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 GLANDULAR LESIONS PITFALLS IN MANAGEMENT Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 Introduction Cervical glandular lesions are much less common than squamous lesion Incidence

More information

Management of Abnormal Cervical Cytology and Histology

Management of Abnormal Cervical Cytology and Histology Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline

More information

I have no financial interests to disclose.

I have no financial interests to disclose. Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests

More information

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today. Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics

More information

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix

More information

Cervical Conization. 1

Cervical Conization.   1 Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly

More information

Understanding Your Pap Test Results

Understanding Your Pap Test Results Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities

More information

Introduction to Colposcopy

Introduction to Colposcopy Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification

More information

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN. CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee

More information

Management that provides continuity of care for women

Management that provides continuity of care for women Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred

More information

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

!#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ !"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

5. Colposcopist performing exam: (Draw SCJ, acetowhite, punctation, mosaics, atypical vessels, and other lesions)

5. Colposcopist performing exam: (Draw SCJ, acetowhite, punctation, mosaics, atypical vessels, and other lesions) Appendix 1 Colposcopy record 1. Medical Record Number: 2. Patient s Name: EXAMPLE 3. Age: 4. Date of visit: / / (Day/Month/Year) 5. Colposcopist performing exam: 6. Did you see the entire suamocolumnar

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

The society for lower genital tract disorders since 1964.

The society for lower genital tract disorders since 1964. The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Twenty-first refresher course. Chan Kit Sheung

Twenty-first refresher course. Chan Kit Sheung Twenty-first refresher course Chan Kit Sheung 7-5-2015 Case 1 Case 1, 29y old, G3P2, referred from MCHC Cervical smear on 27-9-2013: LGSIL, defaulted appointment Cervical smear in 12/2014: negative Colposcopy

More information

Eradicating Mortality from Cervical Cancer

Eradicating Mortality from Cervical Cancer Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus

More information

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013 Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely

More information

Making Sense of Cervical Cancer Screening

Making Sense of Cervical Cancer Screening Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because

More information

Over-diagnoses in Cytopathology: Is histology the gold standard?

Over-diagnoses in Cytopathology: Is histology the gold standard? Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,

More information

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures

More information

Managament of Abnormal Cervical Cytology and Histology

Managament of Abnormal Cervical Cytology and Histology Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic

More information

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK Colposcopic Principles Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK The cervix topics discussed are: original squamous epithelium endocervical epithelium

More information

Conflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives

Conflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives Advanced Colposcopy Conflict of Interest Disclosure Anita L. Nelson, MD Anita L. Nelson, MD Professor OB-GYN David Geffen School of Medicine at UCLA CFHC s 2014 Women s Health Update Berkeley, CA May 20,

More information

Cytology Report Format

Cytology Report Format Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College

More information

COLPOSCOPY MADE EASY AND SIMPLE

COLPOSCOPY MADE EASY AND SIMPLE COLPOSCOPY MADE EASY AND SIMPLE Burton Brodsky M.D. Husband, father of four kids Chief of gynecology University of Toledo Assistant residency director University of Toledo Associate professor university

More information

Your Colposcopy Visit

Your Colposcopy Visit Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to

More information

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before

More information

COLPOSCOPY Equipment and procedure

COLPOSCOPY Equipment and procedure COLPOSCOPY Equipment and procedure Kunter Yüce M.D Professor and Head of Gynecologic Oncology Hacettepe University, Ankara, Turkey President of Turkish Society for Colposcopy and Cervical Pathology Member

More information

Clinical Practice Guidelines June 2013

Clinical Practice Guidelines June 2013 Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early

More information

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse

More information

SOGC / SCC Clinical Practice Guideline

SOGC / SCC Clinical Practice Guideline SOGC / SCC Clinical Practice Guideline Colposcopic Management of Abnormal Cervical Cancer Screening and Histology These Clinical Practice Guidelines have been prepared and approved by the Executive and

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

Cervical Cancer : Pap smear

Cervical Cancer : Pap smear Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective

More information

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 05/01/95 ANY MISSING OR INCOMPLETE TEST RESULTS

More information

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman? Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this

More information

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

SESSION J4. What's Next? Managing Abnormal PAPs in 2014 37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines

More information

E-Newsletter. Newsletter of Indian Society of Colposcopy & Cervical Pathology (Reg.)

E-Newsletter. Newsletter of Indian Society of Colposcopy & Cervical Pathology (Reg.) Volume 3 Issue 3 September - December 2012 Price Rs. 5.00 Indian Society of Colposcopy and Cervical Pathology 2005 (ISCCP) E-Newsletter ISCCP Newsletter of Indian Society of Colposcopy & Cervical Pathology

More information

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida Making sense of the new Pap smear screening guidelines. Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida Case 17 year old G1P0010 with first sexual encounter

More information

BCCCP Approved ICD-9 Code List Fiscal Year 2010

BCCCP Approved ICD-9 Code List Fiscal Year 2010 BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant

More information

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila

More information

Colposcopic evaluation of cervical erosion in symptomatic women

Colposcopic evaluation of cervical erosion in symptomatic women International Journal of Reproduction, Contraception, Obstetrics and Gynecology Patil P et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2207-2211 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172025

More information

VIN/VAIN O C T O B E R 3 RD J M O R G A N

VIN/VAIN O C T O B E R 3 RD J M O R G A N VIN/VAIN O C T O B E R 3 RD 2 0 1 8 J M O R G A N Vaginal Intraepithelial Neoplasia VAIN I, II, III Incidence 0.1/100,000 women in US Mean age 50s (J Womens Health (Larchmt) 2009:18:1731) (J Obstet Gynaecol

More information

Cervical Cancer Screening Guidelines Update

Cervical Cancer Screening Guidelines Update Frontier AIDS Education and Training Center Cervical Cancer Screening Guidelines Update Hillary Liss, MD Harborview Medical Center, Madison and Adult Medicine Clinics Frontier AETC, Medical Program Director

More information

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Cervical Cancer 4/27/2016

Cervical Cancer 4/27/2016 Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical College of Wisconsin May 6, 2016 Cervical Cancer In US about

More information

EFC and European Standards for Colposcopic Evaluation

EFC and European Standards for Colposcopic Evaluation EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic

More information

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z ,,,,, PATHOLOGY Q U I Z,,,,, PATHOLOGY QUIZ CASE HISTORY Alex Ferenczy, MD, Professor of Pathology and Obstetries and Gynaecology, The Sir Mortimer B. Davis ]ewish General HosPital, McGill University This

More information

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose. Well Woman Visits in 2018: How Should We Approach Cervical Cancer Screening and Routine Pelvic Examinations? George F. Sawaya, MD Disclosures I have nothing to disclose. Professor, Obstetrics, Gynecology

More information

Cervical Precancer: Evaluation and Management

Cervical Precancer: Evaluation and Management TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of

More information

Name of Policy: Speculoscopy

Name of Policy: Speculoscopy Name of Policy: Speculoscopy Policy #: 095 Latest Review Date: September 2011 Category: Medicine/OB Gyn Policy Grade: C Background/Definitions: As a general rule, benefits are payable under Blue Cross

More information

Cervical Cancer Screening. David Quinlan December 2013

Cervical Cancer Screening. David Quinlan December 2013 Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Manager @ Harris Health System What is a Pap Smear and when is it recommended? Pap smear The Pap smear is a screening

More information

Human Papillomavirus (HPV) and Cervical Cancer Prevention

Human Papillomavirus (HPV) and Cervical Cancer Prevention Human Papillomavirus (HPV) and Cervical Cancer Prevention MOA Autumn Convention November 3, 2017 David J Boes, DO, FACOOG (Dist.) Associate Professor, MSU-COM 1 Disclosures None relative to this presentation

More information

What is a Pap smear?

What is a Pap smear? Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years

More information

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) ASC refers to cytologic changes suggestive of SIL, which are qualitativley or quantitatively

More information

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3

More information

No Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016

No Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016 Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical Director, PPWI Medical College of Wisconsin May 6,

More information

Comparison and correlation of visual inspection with acetic acid, papanicolaou smear and colposcopy in detection of precancerous cervical lesions

Comparison and correlation of visual inspection with acetic acid, papanicolaou smear and colposcopy in detection of precancerous cervical lesions International Journal of Reproduction, Contraception, Obstetrics and Gynecology Talathi M et al. Int J Reprod Contracept Obstet Gynecol. 2016 Oct;5(10):3384-3389 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014 Streamlining Protocols-From Strategy to Implementation Doreen Ramogola-Masire Botswana UPenn Partnership 18-20 June 2014 Botswana-UPenn Partnership Partnership between Government of Botswana, University

More information

Lauren O Sullivan, D.O. February 19, 2015

Lauren O Sullivan, D.O. February 19, 2015 Lauren O Sullivan, D.O. February 19, 2015 1. Review basics of Pap smear, cervical dysplasia/cancer and HPV infection. 2. Review 2012 updated screening guidelines. 3. Discuss how and where to find updated

More information

PATHOLOGY OF THE UTERINE CERVIX SUMALEE SIRIAUNGKUL, M.D. DEPARTMENT OF PATHOLOGY

PATHOLOGY OF THE UTERINE CERVIX SUMALEE SIRIAUNGKUL, M.D. DEPARTMENT OF PATHOLOGY PATHOLOGY OF THE UTERINE CERVIX SUMALEE SIRIAUNGKUL, M.D. DEPARTMENT OF PATHOLOGY PATHOLOGY OF THE UTERINE CERVIX Anatomy and physiology Benign diseases 1. Infections 2. Benign tumors and tumor-like lesions

More information

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.

More information

BC Cancer Cervix Screening 2015 Program Results. February 2018

BC Cancer Cervix Screening 2015 Program Results. February 2018 BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...

More information

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates

More information

ORIGINAL ARTICLE COLPOSCOPIC FINDINGS IN UNHEALTHY CERVIX AND ITS COMPARISON WITH CYTOLOGY AND HISTOPATHOLOGY

ORIGINAL ARTICLE COLPOSCOPIC FINDINGS IN UNHEALTHY CERVIX AND ITS COMPARISON WITH CYTOLOGY AND HISTOPATHOLOGY COLPOSCOPIC FINDINGS IN UNHEALTHY CERVIX AND ITS COMPARISON WITH CYTOLOGY AND HISTOPATHOLOGY N. Gopal 1, Prashant. S. Joshi 2, Ravindra Pukale 3, Shamashoor 4. 1. Professor, Department of Obstetrics &

More information

High Resolution Anoscopy Overview. Naomi Jay, RN, NP, PhD University of California San Francisco

High Resolution Anoscopy Overview. Naomi Jay, RN, NP, PhD University of California San Francisco High Resolution Anoscopy Overview Naomi Jay, RN, NP, PhD University of California San Francisco Email: naomi.jay@ycsf.edy Disclosures No Disclosures Definition of HRA Examination of the anus, anal canal

More information

Estimated New Cancers Cases 2003

Estimated New Cancers Cases 2003 Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz Estimated New Cancers Cases 2003 Images removed due to copyright reasons.

More information

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Cancer Care Ontario Cervical Cancer Screening Goals Increase patient participation in cervical screening Increase primary care

More information

PREVENTION OF CERVICAL CANCER

PREVENTION OF CERVICAL CANCER PREVENTION OF CERVICAL CANCER Author: Dr R. Fuentes MBchb, Havana Spec. OB,GY-Havana- 2011 CONTENT TABLE Abbreviations 2 Introduction 4 The natural history of Cervical cancer 4 Risk Factors 4 Incidence

More information

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of

More information

What Causes Cervical Cancer? Symptoms of Cervical Cancer

What Causes Cervical Cancer? Symptoms of Cervical Cancer Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through

More information

Understand Your Results

Understand Your Results Understand Your Results The Pap test takes little time and may save your life. This simple screening test checks for cell changes in the cervix, the opening of the uterus. If your Pap results were abnormal,

More information

International Federation of Gynecology and Obstetrics

International Federation of Gynecology and Obstetrics International Federation of Gynecology and Obstetrics Treatment of Cervical Precancerous Lesions using Thermocoagulation(Cold Coagulation) and Cryotherapy General Principles All high grade CIN should be

More information

Cervical Cancer Screening

Cervical Cancer Screening Cervical Cancer Screening MEGAN CHENEY, MD MPH MEDICAL DIRECTOR, THE WOMEN S CENTER ASSISTANT DIRECTOR, BGSMC OBGYN RESIDENCY PROGRAM SECTION CHIEF, THE WOMEN S HEALTH INSTITUTE Objectives Understand proper

More information

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify

More information

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW Boureima Ali Nafissatou and Dong zhao * Department of Gynecology, Shanghai

More information

Human Papillomavirus

Human Papillomavirus Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and

More information

Histopathology: Cervical HPV and neoplasia

Histopathology: Cervical HPV and neoplasia Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about

More information

HPV infections and potential outcomes

HPV infections and potential outcomes CONTENTS Preface by Silvia de Sanjosé... 33 Preface by Jacob Bornstein... 37 Author s note... 39 Acknowledgments... 45 CHAPTER 1 HPV infections and potential outcomes HPV: What it is, where it is and what

More information

Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT

Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT National Cervical Screening Programme National Screening Unit Ministry of Health October 2006 Table of

More information